南美洲和中美洲实验室制定了到 2028 年的测试市场预测 - 按类型（临床生物化学、重症监护、血液学、微生物学、分子诊断、免疫学和其他测试类型）和应用（学术机构、临床研究）划分的 COVID-19 影响和区域分析组织、医院实验室、专科诊断中心等）
No. of Pages: 115 | Report Code: TIPRE00025748 | Category: Life Sciences
No. of Pages: 115 | Report Code: TIPRE00025748 | Category: Life Sciences
实验室开发的测试 (LDT) 是一种体外诊断测试，设计和使用于一个实验室。这些测试可用于估计或区分来自人体解剖学样本的各种分析物材料，例如蛋白质、葡萄糖或胆固醇等化合物或 DNA。实验室和药房自动化体外诊断 (IVD) 方法的扩展预计将推动这一增长，以提供精确、无差错的分析。
南美洲和中美洲实验室开发的测试市场预计将进入美国到 2028 年，将从 2021 年的 8.3455 亿美元增至 12.9392 亿美元；预计 2021 年至 2028 年复合年增长率为 6.5%。推动市场增长的关键因素是癌症和遗传性疾病发病率的增加以及实验室开发测试的产品发布数量的增加。然而，不断变化的监管环境正在阻碍南美洲和中美洲实验室开发测试市场的增长。
癌症是全世界导致死亡的主要原因之一。根据世界卫生组织的数据，2018 年，癌症导致约 960 万人死亡。临床诊断有助于检测早期体征和风险因素，为早期干预铺平道路。实验室开发的测试（LDT）对诊断的每一步都具有决定性的影响，从筛查到预防某些疾病以及疾病发作时的早期诊断。例如，Oncotype DX 实验室测试用于确定化疗是否会使早期乳腺癌患者受益。它还有助于评估疾病复发的可能性；该测试是在乳腺癌手术期间取出的小组织样本上进行的。此外，遗传性疾病发病率的增加也推动了对LDT的需求。由于市场上缺乏基因检测，许多 LDT 可用于基因检测。根据分子病理学协会 2018 年评估，医疗市场上有约 70,000 种基因检测，其中大部分是 LDT。因此，癌症发病率的上升以及人们对早期诊断重要性的认识不断提高，正在推动 LDT 的采用。此外，LDT 是在实验室内开发和使用的，不会分发或出售给其他实验室或医疗机构。因此，新LDT的开发和引入频率很高。此外，SARS-CoV-2 变体的不断出现凸显了识别、追踪和追踪整个病毒基因组突变的必要性。因此，越来越多的开发 LDT 来检测癌症和自身免疫性疾病的研究正在推动市场增长。
新冠肺炎？ 19日大流行对南美洲和中美洲已经负担过重且资金不足的公共医疗系统来说是一次严峻的考验。国营医院和诊所已经因媒介传播疾病、社区获得性感染和高发病率的非传染性疾病 (NCD) 的治疗而承受过重的压力。根据泛美卫生组织 (PAHO) 的数据，自该地区爆发 COVID-19 以来，非传染性疾病的预防和治疗受到严重影响。此外，在南美洲和中美洲，发达国家的国内生产总值（GDP）和中央政府医疗保健支出明显较低。不断增加的 COVID-19 病例严重扰乱了许多慢性疾病的护理，从而阻碍了该地区的市场增长。
南美洲和中美洲实验室开发的测试市场按类型分为临床生物化学、重症监护、血液学、微生物学、分子诊断、免疫学和其他测试类型。血液学部分又细分为凝血和止血、血红蛋白测试、血细胞计数测试等。分子诊断领域预计将在 2021 年占据最大的市场份额。然而，血液学领域预计在预测期内复合年增长率最高。
南部和中部地区美国实验室发达的测试市场按应用细分为学术机构、临床研究组织、医院实验室、专业诊断中心等。医院实验室细分市场预计将在 2021 年占据最大的市场份额。然而，预计专科诊断中心细分市场在预测期内的复合年增长率最高。
南美洲和中美洲实验室开发的测试市场细分
Strategic insights for South and Central America Laboratory Developed Test involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 834.55 Million |
| Market Size by 2028 | US$ 1,293.92 Million |
| Global CAGR (2021 - 2028) | 6.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South and Central America Laboratory Developed Test refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Laboratory Developed Test Market is valued at US$ 834.55 Million in 2021, it is projected to reach US$ 1,293.92 Million by 2028.
As per our report South and Central America Laboratory Developed Test Market, the market size is valued at US$ 834.55 Million in 2021, projecting it to reach US$ 1,293.92 Million by 2028. This translates to a CAGR of approximately 6.5% during the forecast period.
The South and Central America Laboratory Developed Test Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Laboratory Developed Test Market report:
The South and Central America Laboratory Developed Test Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Laboratory Developed Test Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Laboratory Developed Test Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Laboratory Developed Test Market
